Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2019-03-01 | IntelliBio | Series C | Hosen Capital | |
2019-02-28 | HOZ Medical | Series A | HMC Ventures | |
2018-08-30 | K2 Oncology | Series A | DT Capital Partners | |
2018-04-19 | Direct Genomics | Series A | $34.72M | Xiyi Asset Management |
2017-08-30 | Shuidi Huzhu | Series A | $24M | BlueRun Ventures, Gaorong Capital, IDG Capital, Meituan Dianping, Sinovation Ventures, and Tencent Holdings |